Development of a lysophosphatidic acid receptor 1 (LPA1) radioligand for lung imaging with PET

被引：0
|
作者：
Gallezot, Jean-Dominique [1 ]
Nabulsi, Nabeel [1 ]
Holden, Daniel [1 ]
Donnelly, David [2 ]
Cao, Kai [2 ]
Bonacorsi, Samuel [2 ]
Hayes, Wendy [3 ]
Huang, Yiyun [1 ]
Du, Shuyan [3 ]
Carson, Richard [1 ]
机构：
[1] Yale Univ, Diagnost Radiol, New Haven, CT USA
[2] Bristol Myers Squibb Co, Radiochem, Princeton, NJ USA
[3] Bristol Myers Squibb Co, Imaging, Princeton, NJ USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2014年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
96
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EGF and angiotensin II modulate lysophosphatidic acid LPA1 receptor function and phosphorylation state
    Colin-Santana, Christian C.
    Erendira Avendano-Vazquez, S.
    Alcantara-Hernandez, Rocio
    Adolfo Garcia-Sainz, J.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2011, 1810 (12): : 1170 - 1177
  • [32] Lysophosphatidic acid enhanced the osteogenic and angiogenic capability of osteoblasts via LPA1/3 receptor
    Chen, Xiaodan
    Song, Zijun
    Chen, Rui
    Tan, Shuyi
    Huang, Chunhuang
    Liu, Yanhui
    Cheng, Bin
    Fu, Qiang
    CONNECTIVE TISSUE RESEARCH, 2019, 60 (02) : 85 - 94
  • [33] Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors:: Discovery of a LPA1/LPA3 receptor antagonist
    Heise, CE
    Santos, WL
    Schreihofer, AM
    Heasley, BH
    Mukhin, YV
    MacDonald, TL
    Lynch, KR
    MOLECULAR PHARMACOLOGY, 2001, 60 (06) : 1173 - 1180
  • [34] The type 1 lysophosphatidic acid receptor (LPA1): identification of a new therapeutic target for patients with bone metastases
    Peyruchaud, Olivier
    Boucharaba, Ahmed
    Serre, Claire-Marie
    Clezardin, Philippe
    CANCER RESEARCH, 2006, 66 (08)
  • [35] Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling
    Herr, Keira Joann
    Herr, Deron R.
    Lee, Chang-Wook
    Noguchi, Kyoko
    Chun, Jerold
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (37) : 15444 - 15449
  • [36] Structure dependence and species sensitivity of in vivo hepatobiliary toxicity with lysophosphatidic acid receptor 1 (LPA1) antagonists
    Sivaraman, L.
    Gill, M.
    Nelson, D. M.
    Chadwick, K. D.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 438
  • [37] First-in-human evaluation of 18F-BMS-986327 as a novel PET tracer to assess lysophosphatidic acid receptor 1 (LPA1) target engagement in the lung
    Smith, R.
    Donnelly, D.
    Gallezot, J.
    Lu, Y.
    Murphy, B.
    Cheng, P.
    Kim, J.
    Charles, E.
    Du, S.
    Holden, D.
    Najafzadeh, S.
    Gao, H.
    Kapinos, M.
    Ropchan, J.
    Nabulsi, N.
    Huang, H.
    Fischer, A.
    Carson, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [38] Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex
    Beatriz García-Díaz
    Raquel Riquelme
    Isabel Varela-Nieto
    Antonio Jesús Jiménez
    Isabel de Diego
    Ana lsabel Gómez-Conde
    Elisa Matas-Rico
    José Ángel Aguirre
    Jerold Chun
    Carmen Pedraza
    Luis Javier Santín
    Oscar Fernández
    Fernando Rodríguez de Fonseca
    Guillermo Estivill-Torrús
    Brain Structure and Function, 2015, 220 : 3701 - 3720
  • [39] Differential targeting of lysophosphatidic acid LPA1, LPA2, and LPA3 receptor signalling by tricyclic and tetracyclic antidepressants.
    Olianas, Maria C.
    Dedoni, Simona
    Onali, Pierluigi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 959
  • [40] Effects of lysophosphatidic acid and its receptors LPA1/3 on radiation pneumonitis
    Xue, Jianxin
    Gan, Lu
    Li, Xin
    Li, Jian
    Qi, Guohai
    Wu, Yalan
    Fu, Xiaoyue
    Mao, Qing
    Ao, Rui
    Lang, Jingyi
    Lu, You
    ONCOLOGY REPORTS, 2010, 24 (06) : 1515 - 1520
12345